Growth Metrics

Bionano Genomics (BNGO) FCF Margin (2017 - 2025)

Bionano Genomics' FCF Margin history spans 7 years, with the latest figure at 79.68% for Q3 2025.

  • For Q3 2025, FCF Margin rose 13947.0% year-over-year to 79.68%; the TTM value through Sep 2025 reached 64.94%, up 21419.0%, while the annual FY2024 figure was 224.21%, 12708.0% up from the prior year.
  • FCF Margin for Q3 2025 was 79.68% at Bionano Genomics, down from 51.98% in the prior quarter.
  • Across five years, FCF Margin topped out at 43.36% in Q1 2025 and bottomed at 570.47% in Q1 2022.
  • The 5-year median for FCF Margin is 322.07% (2021), against an average of 312.02%.
  • The largest annual shift saw FCF Margin surged 28859bps in 2021 before it plummeted -13158bps in 2022.
  • A 5-year view of FCF Margin shows it stood at 406.57% in 2021, then fell by -1bps to 410.83% in 2022, then soared by 31bps to 284.71% in 2023, then skyrocketed by 72bps to 79.41% in 2024, then decreased by 0bps to 79.68% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's FCF Margin are 79.68% (Q3 2025), 51.98% (Q2 2025), and 43.36% (Q1 2025).